GENE ONLINE|News &
Opinion
Blog

Samsung Biologics
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
GeneOnline’s Weekly News Highlights: July 3-7
2023-07-10
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Samsung Biologics Strikes Deal with GreenLight Bio to Manufacture mRNA Vaccines
2021-11-29
South Korea Approves EUA for Moderna’s COVID-19 Vaccine Produced by Samsung Biologics
2021-10-28
Samsung Biologics Initiates Production of Moderna’s COVID-19 Vaccine
2021-10-15
Samsung Biologics Inks CDMO Deal with Enzolytics on HIV and COVID-19 Antibodies
2021-10-08
Korea’s Local Pharmas Unite to Strengthen mRNA Vaccine Production
2021-06-03
Samsung Biologics to Produce mRNA Vaccine Ingredients in Songdo Facility
2021-06-01
COVID-19: Moderna Enters Manufacturing Agreement with Samsung Biologics after Vaccine Bags Conditional Nod in South Korea
2021-05-23
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
Lilly Partners with Samsung Biologics to Boost Delivery of COVID-19 Antibody Treatments
2020-11-19
Weekly Asia Highlights- South Korea and Australia
2020-08-13
1 2
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top